Cargando…
A survey on Malaysian’s acceptance and perceptions towards COVID-19 booster dose
Progressive reopening of the economy and declaration of COVID-19 as endemic has relaxed social distancing and mask-wearing necessities in Malaysia. The Ministry of Health of Malaysia reported vaccination rate had reached 86.1% for the first dose and 84.3% for the second dose as of April 2023. Howeve...
Autores principales: | Rajakumar, Suresh, Shamsuddin, Noorasyikin, Alshawsh, Mohammed Abdullah, Rajakumar, Sutha, Zaman Huri, Hasniza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565867/ https://www.ncbi.nlm.nih.gov/pubmed/37829192 http://dx.doi.org/10.1016/j.jsps.2023.101797 |
Ejemplares similares
-
Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study
por: Abousheishaa, Aya Ahmed, et al.
Publicado: (2022) -
Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019) -
Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2016) -
Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019) -
Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2015)